glp 1 agonist equivalent doses GLP-1 receptor agonists available Oral GLP-1-Based Therapeutics in the

Learn how GLP-1 drugs can help you lose weight, which ones are best, and where to get them.

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

The clinical data is real

Area covered Therefore, this review aims to summarize recent strategies to address the challenges associated with the oral delivery of GLP-1RAs

Understand their differences in efficacy and safety.

Other combinations of entero-pancreatic hormones including cagrisema (GLP-1/amylin RA) and the triple agonist retatrutide (GLP-1/GIP/glucagon RA) have also progressed to phase 3 trials as obesity treatments and early data suggests that may lead to even greater WL than tirzepatide